35.4 F
New York
Friday, February 26, 2021

Pfizer-BioNTech’s COVID19 Vaccine Candidate Acheive 95% Success

Must read

MongoDB [NASDAQ: MDB] Announces Extended 5-year Collaboration With Google Cloud

MongoDB Inc. , reported an extended five-year collaboration that will stretch out their current go-to-market relationship. Moreover, it will provide a more profound integration...

Humana Inc [NYSE: HUM] Announces Collaboration With Mercy

Mercy and  Humana Inc. announces that the companies have collaborated. Both the companies inked a contract to extend patient access to virtual healthcare...

International Paper [NYSE: IP] Reports Purchase Of Berkley MF LLC

International Paper has purchased Berkley International's Molded Fiber (Pulp) production subsidiary, Berkley MF LLC. Berkley is the provider of essential packaging and e-commerce...

Perspecta [NYSE: PRSP] Received an Award For $38 Million To Continue Supporting DMDC

Perspecta Inc. , reported that the company has been granted an award to keep supporting the Defense Manpower Data Center (DMDC) with a strategic...

Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) have disclosed Wednesday that their COVID-19 vaccine candidate, BNT162b2, has shown a 95% efficacy rate in the final stage. The company has revealed that 170 cases were assessed in the trial. Out of 170, 162 were observed in placebo, and 8 were in the vaccine group.

PFE and BNTX have observed that the efficacy rate remained constant across age, gender, race, and ethnicity demographics. The firms have found efficacy in adults over 65 years of age was over 94%.

Both the partners have earlier declared that their vaccine candidate has shown 90% effectiveness against SARS-CoV-2, a virus that causes COVID-19. All the 43,000 volunteers have shown no concerning symptoms after receiving the doses of vaccine.

BioNTech-Pfizer is planning to send the efficacy data to FDA and EUA and to health authorities around the world. Both the partners are anticipating to produce 50 million vaccine doses in 2020 and up to 1.3 billion doses by the end of 2021.

Shares of Pfizer Inc. (NYSE: PFE) went up 1.36% at $36.53 during the trading session of Wednesday. It had a trading volume of 46.3 million as compared to the average volume of 31.12 million. In the past 52-weeks of trading, this company share has changed between the 52-weeks low and high range of $26.42 and $39.79, respectively. This company has a total market capitalization of $194.77 billion at the time of writing.

More articles

Latest article

SG Blocks [NASDAQ: SGBX] Continues Growth Through The Execution Of 19-acre Acquisition Contract

SG Blocks, Inc. executes the contract to purchase the 19 acre Echo sites and all of its multiple structures. The company reported the...

HP Inc [NYSE: HPQ] Enters Into A Contract To Purchase HyperX

HP Inc. revealed that the company entered into a contract to purchase HyperX. It is the gaming subsidiary of Kingston Technology Company. Moreover,...

AT&T [NYSE: T] Might Sell Its Large Minority Stake At Direct TV/ U-Verse Operation To TPG

AT&T is approaching a deal to sell a significant minority stake in its DirecTV, AT&T TV Now, and U-Verse business to TPG. Additionally,...

Wipro [NYSE: WIT] Entered Into A Collaborative Agreement With Uptake

Uptake revealed that the company has collaborated with Wipro limited . The companies inked the agreement to deliver industrial intelligence for the utilities, chemical...

eXp World Holdings [NASDAQ: EXPI] Set Its Footprint In Brazil

eXp World Holdings, Inc. in order to expand its business operations has set its footprint into Brazil, under the eXp Brazil flag. Along...

L3Harris [NYSE: LHX] Grabbed A Contract Totaling Up To $137M For 4 Navigation Payload MDU

L3Harris Technologies announced that the company has grabbed a contract that totals up to $137 million for four route payload Mission Data Units...

VerifyMe [NASDAQ: VRME] Nabs Purchase Order For 2M Pre-Printed Anti-Counterfeiting Labels

VerifyMe, Inc revealed that the company has been awarded an initial purchase order for PPE anti-counterfeit technology. The company obtained a request for...

NeoGames [NASDAQ: NGMS] Announces The Go-Live Of Its Games With Austrian Lotteries

NeoGames S.A. expands further into the European lottery market by launching its first set of games. The company revealed that it signed an...